摘要
当前,用于治疗结构性心脏病的医疗器械领域发展迅速,是我国创新产品审查中的重要部分。国内外重点发展的方向有经导管瓣膜置换修复、房室瓣瓣环环缩、生物可吸收药物洗脱冠脉药物支架、小口径人工血管、生物可吸收介入封堵、心房分流、心室减容。
The field of medical devices for the treatment of structural heart disease has developed rapidly and is an important part of the review of innovative products in China.The key development directions at home and abroad include transcatheter valve replacement repair,atrioventricular annular contraction,bioresorbable drug-eluting coronary drug stents,small-caliber artificial blood vessels,bioresorbable interventional occlusion,atrial shunting,and ventricular volume reduction.
作者
焦永哲
姜熙
缪辉
张争辉
马金竹
段青姣
崔红
JIAO Yong-zhe;JIANG Xi;MIAO Hui;ZHANG Zheng-hui;MA Jin-zhu;DUAN Qing-jiao;CUI Hong(Supervision and Testing Center for Medical Devices of Tianjin,Tianjin 300382)
出处
《中国医疗器械信息》
2023年第23期8-11,共4页
China Medical Device Information
关键词
结构性心脏病
创新
structural heart disease
innovation
